If you're interested in cellular energy and longevity support, **NMN** (nicotinamide mononucleotide) is an NAD+ precursor with growing clinical interest, and this product gives you 175mg per capsule. The catch is that most clinical trials use 250–500mg/day, so at one capsule you're getting about 35–70% of the doses that have shown measurable increases in blood NAD+ levels. You'd need two capsules daily to reach the 250mg minimum studied dose.

NMN has growing clinical evidence for raising NAD+ levels in humans, with several RCTs published since 2022 showing improvements in markers related to energy metabolism and cellular repair. The capsule form is straightforward, and at 60 capsules per container you get one to two months depending on your dose.

The underdosing at one capsule is the main concern. If you follow the label's suggested single capsule, you're below the clinical threshold where benefits have been demonstrated. Doubling up brings you into range but cuts your supply in half and increases your cost per effective dose.